Eagle Pharmaceuticals (EGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 09-2014 | |
| Sales | 236,707 | 189,482 | 66,227 | 0 | 19,099 |
| Cost of Goods | 57,186 | 55,306 | 15,647 | N/A | 11,714 |
| Gross Profit | 179,521 | 134,176 | 50,580 | N/A | 7,385 |
| Operating Expenses | 105,717 | 81,131 | 48,667 | 0 | 26,856 |
| Operating Income | 73,990 | 53,351 | 2,560 | N/A | -18,757 |
| Interest Expense | 1,136 | 8 | 11 | 0 | 8 |
| Other Income | 91 | 84 | 25 | 0 | -507 |
| Pre-tax Income | 72,945 | 53,427 | 2,574 | 0 | -19,272 |
| Income Tax | 21,002 | -28,026 | 3 | N/A | -1,295 |
| Net Income Continuous | 51,943 | 81,453 | 2,571 | N/A | -17,977 |
| Net Income | $51,943 | $81,453 | $2,571 | $N/A | $-17,977 |
| EPS Basic Total Ops | 3.44 | 5.24 | 0.17 | N/A | -1.97 |
| EPS Basic Continuous Ops | 3.44 | 5.24 | 0.17 | N/A | -1.81 |
| EPS Diluted Total Ops | 3.27 | 4.96 | 0.16 | N/A | -1.97 |
| EPS Diluted Continuous Ops | 3.27 | 4.96 | 0.16 | N/A | -1.81 |
| EPS Diluted Before Non-Recurring Items | 3.37 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $77,959 | $54,940 | $2,672 | $N/A | $-18,653 |